ABCC6 deficiency and bone loss: A double benefit of etidronate for patient presenting with pseudoxanthoma elasticum?

Saved in:
Bibliographic Details
Published in:Experimental dermatology 2022-10, Vol.31 (10), p.1635-1637
Main Authors: Kauffenstein, Gilles, Chappard, Daniel, Leftheriotis, Georges, Martin, Ludovic
Format: Article
Language:English
Subjects:
ABCC6
ageing
Bioengineering
Bone Diseases, Metabolic
Bone loss
Etidronic acid
Etidronic Acid - therapeutic use
Humans
Life Sciences
Multidrug Resistance-Associated Proteins - genetics
Mutation
Pseudoxanthoma Elasticum - drug therapy
Pseudoxanthoma Elasticum - genetics
PXE
pyrophosphate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0906-6705
1600-0625
DOI:10.1111/exd.14636